Reistone Biopharma Company Limited is a clinical stage biopharmaceutical company focused on developing novel medicines for life threatening autoimmune diseases. Developing therapies for diseases requires new approaches and strong collaboration between scientists, industry, regulators and patient groups. Reistone was forged from the company’s close collaborations with key stakeholders and leading pharmaceutical companies dedicated to transforming new biotechnology insights into breakthrough medicine for significant unmet medical needs in China as well globally.
Our mission is to work together to deliver innovative and accessible medicines to patients in the field of autoimmune disorders. Our strategy is to harness innovative science to produce the promise of the best medicines. This is inspired by our vision, to be a globally recognized leader committed to bring the best innovative medicines to the world helping patients globally from China and beyond.
We believe that the key success factors in drug research and development are to combine innovative clinical development strategy/expertise and efficient drug development processes. Our team is built with senior people who have worked in top multinational pharmaceutical companies for a long time and want to make a direct impact for patients around the globe with Reistone.